Menu
GeneBe

GLYCTK

glycerate kinase

Basic information

Region (hg38): 3:52287088-52295257

Links

ENSG00000168237NCBI:132158OMIM:610516HGNC:24247Uniprot:Q8IVS8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • D-glyceric aciduria (Supportive), mode of inheritance: AR
  • D-glyceric aciduria (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
D-glyceric aciduriaARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Neurologic4599249; 2537226; 20949620

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GLYCTK gene.

  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GLYCTK gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
36
clinvar
4
clinvar
41
missense
87
clinvar
11
clinvar
5
clinvar
103
nonsense
1
clinvar
1
start loss
0
frameshift
1
clinvar
2
clinvar
4
clinvar
7
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
2
2
1
5
non coding
5
clinvar
5
Total 1 2 94 52 9

Variants in GLYCTK

This is a list of pathogenic ClinVar variants found in the GLYCTK region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-52290363-C-T Benign (Jul 19, 2023)732033
3-52290370-C-G Uncertain significance (Nov 27, 2023)2072805
3-52290371-G-T not specified Uncertain significance (Jun 03, 2024)3281686
3-52290379-C-T D-Glyceric aciduria Conflicting classifications of pathogenicity (Dec 08, 2022)1878259
3-52290380-G-A not specified Uncertain significance (May 08, 2023)1406594
3-52290385-C-T not specified Uncertain significance (May 14, 2024)3281688
3-52290392-A-G not specified Likely benign (Nov 13, 2023)3100434
3-52290394-C-T Uncertain significance (Mar 26, 2022)1965631
3-52290399-C-T Likely benign (Aug 17, 2023)1646697
3-52290401-TCTG-T D-Glyceric aciduria Uncertain significance (Dec 18, 2017)522994
3-52290406-C-T Uncertain significance (Aug 12, 2022)1386071
3-52290413-C-T Likely benign (Sep 20, 2021)1590817
3-52290421-C-T Benign (Jan 15, 2024)727443
3-52290422-G-A Likely benign (Nov 25, 2023)1597795
3-52290454-G-A D-Glyceric aciduria Uncertain significance (Jan 01, 2016)930336
3-52290472-A-G Uncertain significance (May 08, 2023)1968295
3-52290494-C-T Uncertain significance (Jun 13, 2022)1934880
3-52290495-G-A GLYCTK-related disorder Likely benign (Oct 01, 2022)734926
3-52290511-C-T not specified Uncertain significance (Sep 01, 2021)2247791
3-52290514-G-C not specified Uncertain significance (Nov 07, 2022)2322651
3-52290519-A-G Likely benign (Oct 24, 2022)1567549
3-52290528-C-T Likely benign (Aug 01, 2022)2653875
3-52290536-G-A not specified Uncertain significance (Mar 22, 2023)2528473
3-52290553-C-T not specified Uncertain significance (Sep 14, 2022)2399107
3-52290559-C-T Uncertain significance (Jun 22, 2022)1924189

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GLYCTKprotein_codingprotein_codingENST00000436784 48168
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
9.65e-110.04531256810611257420.000243
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2283333221.040.00002003298
Missense in Polyphen8483.2881.0086906
Synonymous-0.5021471391.050.000007771232
Loss of Function-0.1711514.31.056.14e-7154

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0009170.000915
Ashkenazi Jewish0.000.00
East Asian0.0001110.000109
Finnish0.00004660.0000462
European (Non-Finnish)0.0002120.000211
Middle Eastern0.0001110.000109
South Asian0.0002630.000261
Other0.000.00

dbNSFP

Source: dbNSFP

Pathway
Glycerolipid metabolism - Homo sapiens (human);Glycine, serine and threonine metabolism - Homo sapiens (human);Pentose phosphate pathway - Homo sapiens (human);Glyoxylate and dicarboxylate metabolism - Homo sapiens (human);3-Phosphoglycerate dehydrogenase deficiency;Familial lipoprotein lipase deficiency;Non Ketotic Hyperglycinemia;Glycine and Serine Metabolism;Glycerolipid Metabolism;Glycerol Kinase Deficiency;Dimethylglycine Dehydrogenase Deficiency;Hyperglycinemia, non-ketotic;D-glyceric acidura;Dimethylglycine Dehydrogenase Deficiency;Sarcosinemia;Dihydropyrimidine Dehydrogenase Deficiency (DHPD);Fructose metabolism;Metabolism of carbohydrates;Metabolism;Fructose catabolism (Consensus)

Recessive Scores

pRec
0.186

Intolerance Scores

loftool
0.810
rvis_EVS
0.24
rvis_percentile_EVS
69.46

Haploinsufficiency Scores

pHI
0.0397
hipred
N
hipred_score
0.177
ghis
0.383

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.766

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Glyctk
Phenotype

Gene ontology

Biological process
protein phosphorylation;fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate
Cellular component
cytoplasm;mitochondrion;Golgi apparatus;cytosol
Molecular function
protein binding;ATP binding;glycerate kinase activity